Glycobiology, 2000, Vol. 10, No. 1 77-87
© 2000 Oxford University Press
Truncated N-glycans affect protein folding in the ER of CHO-derived mutant cell lines without preventing calnexin binding
Unité de Génétique Somatique, URA CNRS 1960, Institut Pasteur, 25 Rue du Docteur Roux, 75724 Paris Cedex 15, France, 2Laboratoire de Chimie Biologique, UMR CNRS 8576, Université des Sciences et Technologies de Lille, 59655 Villeneuve dAscq Cedex, France, and 3Department of Biochemistry, AMC, University of Amsterdam, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands
The involvement of N-glycans in the folding of influenza virus hemagglutinin (HA) was analyzed in two CHO-derived glycosylation mutants exhibiting a thermosensitive defect for secretion of human placental alkaline phosphatase. Truncated Man5GlcNAc2 oligosaccharides with one or three glucose residues are attached to proteins of the MadIA214 and B3F7AP2-1 mutant cells, respectively. Newly synthesized proteins retained in these cells carry a Man4 trimmed glycan generated by a mannosidase different from the ER mannosidases I and II and suggesting a recycling through the Golgi complex. The glucosidase inhibitor castanospermine affects the binding of HA folding intermediates to the lectin-like chaperone calnexin in B3F7AP2-1 but not in MadIA214 cells. We demonstrated that calnexin interacts in vivo with truncated Man5 derivatives. In MadIA214 cells, this is only possible when Man5GlcNAc2 on protein becomes reglucosylated. The pattern of intermediates seen during the folding of HA in the MadIA214 and B3F7AP2-1 mutant cell lines is different than in control cells. We also observed a variable occupancy of the seven glycosylation-sites. However, even under conditions that restore glycosylation of all sites, the folding intermediates of HA in the mutant cells still remain heterogeneous. Our results demonstrate that addition of truncated N-glycans interferes extensively with the folding of newly synthesized proteins in vivo.
1 To whom correspondence should be addressed
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. B. Free, L. A. Hazelwood, D. M. Cabrera, H. N. Spalding, Y. Namkung, M. L. Rankin, and D. R. Sibley D1 and D2 Dopamine Receptor Expression Is Regulated by Direct Interaction with the Chaperone Protein Calnexin J. Biol. Chem., July 20, 2007; 282(29): 21285 - 21300. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Grasberger, X. De Deken, F. Miot, J. Pohlenz, and S. Refetoff Missense Mutations of Dual Oxidase 2 (DUOX2) Implicated in Congenital Hypothyroidism Have Impaired Trafficking in Cells Reconstituted with DUOX2 Maturation Factor Mol. Endocrinol., June 1, 2007; 21(6): 1408 - 1421. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Duvet, A. Op De Beeck, L. Cocquerel, C. Wychowski, R. Cacan, and J. Dubuisson Glycosylation of the hepatitis C virus envelope protein E1 occurs posttranslationally in a mannosylphosphoryldolichol-deficient CHO mutant cell line Glycobiology, February 1, 2002; 12(2): 95 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ermonval, C. Kitzmuller, A. M. Mir, R. Cacan, and N. E. Ivessa N-glycan structure of a short-lived variant of ribophorin I expressed in the MadIA214 glycosylation-defective cell line reveals the role of a mannosidase that is not ER mannosidase I in the process of glycoprotein degradation Glycobiology, July 1, 2001; 11(7): 565 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Anand, J. S. Rush, S. Ray, M.-A. Doucey, J. Weik, F. E. Ware, J. Hofsteenge, C. J. Waechter, and M. A. Lehrman Requirement of the Lec35 Gene for All Known Classes of Monosaccharide-P-Dolichol-dependent Glycosyltransferase Reactions in Mammals Mol. Biol. Cell, February 1, 2001; 12(2): 487 - 501. [Abstract] [Full Text] |
||||



